Nichols Weston
10% Owner · Cullinan Therapeutics, Inc.
Every open-market stock purchase Nichols Weston has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- CGEMCullinan Therapeutics, Inc.
One purchase totalling $1.4M at an average of $8.40 per share. See all insider buying in CGEM →
Avg price paid$8.40Latest price—Market cap$1.1B - TCRX−63.8% vs price paidTScan Therapeutics, Inc.
One purchase totalling $290.0K at an average of $2.90 per share; the stock last traded at $1.05. See all insider buying in TCRX →
Avg price paid$2.90Latest price$1.05Market cap$68.6M - PASGPassage BIO, Inc.
One purchase totalling $138.3K at an average of $6.99 per share. See all insider buying in PASG →
Avg price paid$6.99Latest price—Market cap$15.1M
Cluster participation
Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.
All reported buys
Follow new qualifying clusters involving Nichols Weston or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Nichols Weston's Form 4 filings on SEC EDGAR (CIK 1746376) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.